Supporting patients through opioid analgesic discontinuations
The timelines and alternative options for thousands of patients living with pain when oral morphine and oxycodone are discontinued this year.
What impact will Wegovy have on the obesity epidemic?
The latest injectable glucagon-like peptide-1 receptor agonist, Wegovy, became available in Australia last week (5 August 2024).
Is it still safe to use azithromycin?
The TGA has issued a warning after receiving reports possibly associating azithromycin with cardiovascular death in several patients.
Meet Depinder Chhibber, MasterChef’s pharmacist contestant
While Depinder Chhibber MPS explores her passion for cooking on the current season of MasterChef, she remains a pharmacist at heart.
New migraine treatment approved
The TGA has approved a new preventative treatment for migraine, with a new medicine that targets the calcitonin gene-related peptide receptor.
Patients experiencing migraine will...
New normal for SABA supply has begun
The Schedule 3 entry for salbutamol was updated on 1 October 2023, coinciding with a new treatment guideline around asthma relievers.
